trial
as of 2026-07-01Oxytocin Treatment of Social Cognitive and Functional Deficits in Schizophrenia
NCTId NCT01394471
at a glance
Phase 1 · Completed
Enrollment 68 (actual)
Sponsored by University of North Carolina, Chapel Hill
Primary completion 2015-01
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 1
Status
Completed
Enrollment
68 (actual)
Study type
Interventional
Allocation
Randomized
Model
Single Group
Masking
Quadruple
Start
2011-07
Primary completion
2015-01
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Sponsors
University of North Carolina, Chapel HillLead Sponsor
National Institute of Mental Health (NIMH)Collaborator
Investigators
2
Cort A Pedersen, MDPrincipal Investigator
David L. Penn, PhDPrincipal Investigator
Sites
1 total
Chapel Hill, United States
Facts & assertions
4 sourced
Enrollment
68
Phase
PHASE1
Primary Completion Date
2015-01
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
collaborator
indication
investigator
person
person